Professor, PediatricsDr. Schleiss received his M.D. degree from the Oregon Health and Sciences University, Portland, Oregon. He completed his residency at Doernbecher Children’s Hospital, Oregon Health and Sciences University, Portland, Oregon and his Pediatric Infectious Diseases fellowship at Children’s Hospital Medical Center, University of Washington, Seattle, Washington and a fellowship in Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington
Honors
| 1979 | Associate Member, Sigma Xi Research Honor Society, Stanford, California |
| 1995 | Distinguished Service Award, Association for Retarded Citizens (ARC) |
| 1999 | Mead-Johnson Teaching Award |
| 2000-2003 | Society for Pediatric Research, Council Member (www.aps-spr.org) |
| 2001-present | Council Member, Federation of Pediatric Organizations (FOPO) and Pediatric Education Steering Committee (PESC), www.fopo.org |
| 2003, 2004 | Golden Spoon House Staff Teaching Award |
| 2005-present | Society for Pediatric Research, Secretary - Treasurer ( www.aps-spr.org ) |
Selected Recent Publications
Schleiss MR, Jensen NJ. Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection. J Virol Methods. 2003;108(1):59-65.
Schleiss MR, Bourne N, Bravo FJ, et al. Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection. J Virol Methods. 2003;108(1):103-10.
Schleiss MR. Vertically transmitted herpesvirus infections. Herpes. 2003;10(1):4-11.
Xanthakos SA, Schleiss MR. Glycoprotein B genotyping of cytomegalovirus strains isolated in a pediatric population. Pediatr Infect Dis J. 2003;22(5):462-3.
Haggerty SM, Schleiss MR. A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus. Virus Genes. 2002;25(3):271-9.
Penfold M, Miao Z, Wang Y, Haggerty S, Schleiss MR. A macrophage inflammatory protein homolog encoded by guinea pig cytomegalovirus signals via CC chemokine receptor 1. Virology. 2003;316(2):202-12.
Schleiss MR, Bourne N, Bernstein DI. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis. 2003;188(12):1868-74.
McGregor A, Schleiss MR. Herpesvirus genome mutagenesis by transposon-mediated strategies. Methods Mol Biol. 2004;256:281-302.
McGregor A, Liu F, Schleiss MR. Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone. Virus Res. 2004;101(2):101-8.
Schleiss MR, Bourne N, Stroup G, et al. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis. 2004;189(8):1374-81.
McGregor A, Liu F, Schleiss MR. Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83). J Virol. 2004;78(18):9872-89.
Blackman SC , Lurain NS , Witte DP, Filipovich AH, Groen P, Schleiss MR. Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency. J Pediatr Hematol Oncol. 2004;26(9):601-5.
Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther. 2004;2(3):389-403.
Schleiss MR, Bernstein DI, Passo M, Parker S, Meric C, Verdier F, Newkirk MM. Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects. Vaccine. 2004;23(5):687-92.
Schleiss MR, Bernstein DI, McVoy MA, Stroup G, Bravo F, Creasy B, McGregor A, Henninger K, Hallenberger S. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs. Antiviral Res. 2005;65(1):35-43.
Schleiss MR. Antiviral therapy of congenital cytomegalovirus infection. Semin Pediatr Infect Dis. 2005;16(1):50-9.
Schleiss MR, Heineman TC. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Rev Vaccines. 2005;4(3):381-406.
Madden C, Wiley S, Schleiss MR, Benton C, Meinzen-Derr J, Greinwald J, Choo D. Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2005;69(9):1191-8.